CVS Health Corporation (CVS) Shares Sold by UMB Bank N A MO

UMB Bank N A MO cut its stake in shares of CVS Health Corporation (NYSE:CVS) by 3.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 138,582 shares of the pharmacy operator’s stock after selling 5,495 shares during the quarter. UMB Bank N A MO’s holdings in CVS Health Corporation were worth $11,150,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. Keel Point LLC lifted its holdings in CVS Health Corporation by 0.7% in the 1st quarter. Keel Point LLC now owns 3,296 shares of the pharmacy operator’s stock worth $259,000 after purchasing an additional 22 shares in the last quarter. First City Capital Management Inc. lifted its holdings in CVS Health Corporation by 0.3% in the 1st quarter. First City Capital Management Inc. now owns 12,771 shares of the pharmacy operator’s stock worth $1,003,000 after purchasing an additional 40 shares in the last quarter. Elefante Mark B lifted its holdings in CVS Health Corporation by 0.7% in the 2nd quarter. Elefante Mark B now owns 6,400 shares of the pharmacy operator’s stock worth $515,000 after purchasing an additional 45 shares in the last quarter. Traynor Capital Management Inc. lifted its holdings in CVS Health Corporation by 1.3% in the 2nd quarter. Traynor Capital Management Inc. now owns 3,676 shares of the pharmacy operator’s stock worth $290,000 after purchasing an additional 48 shares in the last quarter. Finally, Norway Savings Bank raised its holdings in shares of CVS Health Corporation by 0.3% during the 2nd quarter. Norway Savings Bank now owns 17,014 shares of the pharmacy operator’s stock worth $1,368,000 after acquiring an additional 50 shares in the last quarter. Institutional investors own 81.59% of the company’s stock.

CVS has been the topic of several analyst reports. BidaskClub downgraded CVS Health Corporation from a “hold” rating to a “sell” rating in a research report on Friday, August 25th. Loop Capital initiated coverage on CVS Health Corporation in a research report on Thursday, August 24th. They set a “hold” rating and a $83.00 target price on the stock. Guggenheim reissued a “buy” rating on shares of CVS Health Corporation in a research report on Monday, July 3rd. Needham & Company LLC reissued a “hold” rating on shares of CVS Health Corporation in a research report on Sunday, September 10th. Finally, Oppenheimer Holdings, Inc. reaffirmed a “buy” rating and issued a $95.00 price objective on shares of CVS Health Corporation in a research report on Monday, October 9th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have issued a buy rating to the company. CVS Health Corporation has a consensus rating of “Buy” and an average price target of $87.98.

In other CVS Health Corporation news, EVP Thomas M. Moriarty sold 90,267 shares of CVS Health Corporation stock in a transaction that occurred on Monday, September 11th. The shares were sold at an average price of $79.61, for a total value of $7,186,155.87. Following the transaction, the executive vice president now owns 70,102 shares in the company, valued at $5,580,820.22. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Richard J. Swift sold 2,500 shares of CVS Health Corporation stock in a transaction that occurred on Wednesday, August 16th. The stock was sold at an average price of $79.62, for a total transaction of $199,050.00. Following the completion of the transaction, the director now owns 3,258 shares in the company, valued at approximately $259,401.96. The disclosure for this sale can be found here. In the last three months, insiders have sold 716,625 shares of company stock worth $58,318,431. 0.61% of the stock is owned by corporate insiders.

TRADEMARK VIOLATION WARNING: “CVS Health Corporation (CVS) Shares Sold by UMB Bank N A MO” was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this article on another website, it was stolen and republished in violation of US & international copyright and trademark laws. The original version of this article can be read at https://www.dispatchtribunal.com/2017/10/28/umb-bank-n-a-mo-has-11-15-million-position-in-cvs-health-corporation-cvs.html.

Shares of CVS Health Corporation (NYSE:CVS) opened at 68.99 on Friday. The stock has a market capitalization of $70.13 billion, a PE ratio of 13.74 and a beta of 0.92. CVS Health Corporation has a 1-year low of $68.16 and a 1-year high of $87.93. The firm has a 50-day moving average price of $78.64 and a 200-day moving average price of $78.69.

CVS Health Corporation (NYSE:CVS) last released its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The company had revenue of $45.69 billion for the quarter, compared to analysts’ expectations of $45.36 billion. During the same quarter in the previous year, the company posted $1.32 earnings per share. The business’s revenue for the quarter was up 4.5% compared to the same quarter last year. On average, equities research analysts forecast that CVS Health Corporation will post $5.88 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, November 3rd. Investors of record on Tuesday, October 24th will be issued a dividend of $0.50 per share. The ex-dividend date is Monday, October 23rd. This represents a $2.00 annualized dividend and a yield of 2.90%. CVS Health Corporation’s payout ratio is 39.92%.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply